CAOW HEMOSTASIS SYSTEM— 510(k) K972689

Substantially Equivalent

Anlam Corp.

FDA 510(k) clearance K972689 for CAOW HEMOSTASIS SYSTEM, Substantially Equivalent on 1998-08-27. Applicant: Anlam Corp..

Clearance details

Applicant: Anlam Corp.
Product code: Code DXC
Advisory panel: Cardiovascular
Date received: 1997-07-17
Decision date: 1998-08-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Edmonton, Alberta, CA

Download summary PDF View on FDA.gov ↗

Adverse events under product code DXC

product code DXC

Death: 14
Injury: 442
Malfunction: 2,209
Other: 1
Total: 2,666

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.